# Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer

> **NCT00838578** · PHASE1,PHASE2 · TERMINATED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 65 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** KRN330
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT00838578
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-10
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Per protocol, the study was terminated based on interim analysis results
- **Last updated:** 2024-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838578, "Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00838578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*